Name: UMIN ID:
Unique ID issued by UMIN | UMIN000026197 |
---|---|
Receipt number | R000030067 |
Scientific Title | A phase II trial of induction erlotinib followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 EGFR mutated non-small cell lung cancer. |
Date of disclosure of the study information | 2017/02/17 |
Last modified on | 2017/06/01 16:58:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/02/17 18:04:34 | ||
2 | Update | 2017/02/17 18:04:57 | UMIN ID1 |
|
3 | Update | 2017/06/01 16:58:16 | Anticipated trial start date |